Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 6/20 | 0.48 |
| ▸ | ATXN2 | Q99700 | 6/20 | 0.48 |
| ▸ | DGAT2 | Q96PD7 | 1/20 | 0.45 |
| ▸ | MAPK7 | Q13164 | 7/20 | 0.37 |
| ▸ | FPR2 | P25090 | 1/20 | 0.37 |
| ▸ | LIPE | Q05469 | 2/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16962030 | 1.00 | ENPP2 (0.48) | ENPP2ATXN2DGAT2MAPK7FPR2 | |
| SCHEMBL21323238 | 1.00 | ENPP2 (0.48) | ENPP2ATXN2DGAT2MAPK7FPR2 | |
| SCHEMBL16963324 | 0.86 | ENPP2 (0.55) | ENPP2ATXN2DGAT2MAPK7LIPE | |
| SCHEMBL17310878 | 0.86 | ENPP2 (0.55) | ENPP2ATXN2DGAT2MAPK7LIPE | |
| SCHEMBL17310877 | 0.86 | ENPP2 (0.55) | ENPP2ATXN2DGAT2MAPK7LIPE | |
| SCHEMBL21323023 | 0.86 | ENPP2 (0.51) | ENPP2ATXN2DGAT2LIPEHSD11B1 | |
| SCHEMBL16963143 | 0.86 | ENPP2 (0.51) | ENPP2ATXN2DGAT2LIPEHSD11B1 | |
| SCHEMBL16962449 | 0.85 | EPHX2 (0.46) | ENPP2ATXN2DGAT2LIPE | |
| SCHEMBL22607355 | 0.84 | ENPP2 (0.49) | ENPP2ATXN2DGAT2FPR2LIPE | |
| SCHEMBL16963182 | 0.83 | ATXN2 (0.40) | ENPP2ATXN2DGAT2LIPE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2900669-B1 | HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES | HOFFMANN LA ROCHE (CH) | 2019-09-04 | — | — | EP | disclosed |